The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...

STORY: Shares of Pfizer rose as much as four percent in Monday morning trading after activist investor Starboard Value took ...

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine.

RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer to push for strategic changes in the U.S.

The recommendations, to administer both the shot and the antibody or either, come after the WHO's strategic advisory group on ...

Pfizer’s RSV vaccine, Abrysvo, generated $515 million in revenue in 2023. Pharma giant Pfizer said on Tuesday that it plans to seek regulatory approval to expand the allowed use of its RSV vaccine, ...